Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Homozygous Familial Hypercholesterolemia
Clinical trial NCT04659863 · COMPLETED
Trial details
- NCT number
- NCT04659863
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-16
- Primary completion
- 2023-10-30
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.